
Thymosin Alpha-1
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterImmune System Optimizer
Trains your immune system's T-cells to fight infections and strengthen defenses.
Choose your supply
Extra 10% off your first order · use code WELCOME10 at checkout (stacks with the supply discount above).
Frequently paired with
What it supports
- Enhanced immune system function
- Increased T-cell production and activity
- Better response to vaccines
- May support cancer treatment outcomes
- Reduced frequency of infections
- Modulates inflammatory responses
- Supports chronic infection management
The details
- Administration
- Subcutaneous injection
- Format
- 5mg/mL, 5mL vial
- Typical dosing
- 1.6mg subcutaneously 2-3 times weekly
- Best for
- Immune resilience, vaccine enhancement, recovery
- Pairs well with
- Epitalon, Selank, NAD+
- Mechanism
- Thymosin Alpha-1 stimulates T-cell differentiation and function, increases natural killer cell activity, and modulates cytokine production. It helps balance immune responses without causing overactivation, training the immune system to respond appropriately.
How it works
Signal
Thymosin Alpha-1 is given as a subcutaneous injection a few times a week, on a provider-determined schedule.
Cellular response
TA-1 stimulates T-cell differentiation and function, increases natural-killer-cell activity, and modulates cytokine production. It helps balance immune responses without overactivation — training the immune system to respond appropriately rather than just turning everything up.
Outcome
Over the following weeks most people notice steadier energy and feeling less run-down first (weeks 1–2), then fewer sick days and infections that resolve faster (weeks 2–4), then a measurable drop in how often they get sick — closer to how their immune system worked a decade ago (weeks 4–12).
Sources & references
30 years of clinical evidence (review)
Dominari A et al. World J Virol. 2020;9(5):67–78.
View sourceFlu-vaccine enhancement: 19% → 6% infection rate
Ershler WB et al. Ann N Y Acad Sci. 2007;1112:375–384.
View sourceSepsis meta-analysis: reduced mortality
Liu F et al. BMC Infect Dis. 2016;16:488.
View sourceThymosin alpha-1 in viral hepatitis treatment
Journal of Hepatology, 2001
View sourceThymalfasin immunomodulatory effects
Expert Opinion on Biological Therapy, 2018
View sourceAdjunct therapy in cancer and immune-compromised patients
Annals of the New York Academy of Sciences, 2012
View sourceThymosin alpha-1 in severe COVID-19 outcomes
International Immunopharmacology, 2020
View source
Common questions
Important safety information
Thymosin Alpha-1 is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • Generally very well tolerated
- • Rare injection site reactions
- • Monitor in autoimmune conditions
- • Requires licensed provider supervision


